| (a) | by inserting, immediately after item (10) of paragraph 1, the following item:| “(11) | N,N-Diethyl-3-hydroxy-7-methyl-2-oxo-4,6,6a,7,8,9‑hexahydroindolo-[4,3-fg]quinoline-9-carboxamide (also known as 2-Oxo-3-hydroxy-LSD) and its acyclic secondary and tertiary amide structural isomers”; |
|
|
| (b) | by deleting items (13), (14) and (15) of paragraph 1 and substituting the following items:| “(13) | 2,5-Dimethoxy-α-methylphenethylamine (also known as 2,5-Dimethoxyamphetamine or DMA) and its dimethoxy positional isomers in the phenyl ring | | (14) | N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as 3,4-Methylenedioxymethamphetamine or MDMA) | | (15) | 3-(1,2-Dimethylhepty1)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (also known as DMHP)”; |
|
|
| (c) | by deleting item (17) of paragraph 1 and substituting the following item:| “(17) | 4-Ethyl-2,5-dimethoxy-α-methylphenethylamine (also known as DOET)”; |
|
|
| (d) | by deleting item (25) of paragraph 1 and substituting the following item:| “(25) | 3-Methoxy-α-methyl-4,5‑(methylenedioxy)phenethylamine (also known as 5-methoxy-MDA or MMDA)”; |
|
|
| (e) | by deleting item (28) of paragraph 1 and substituting the following item:| “(28) | N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine (also known as N-Hydroxy MDA)”; |
|
|
| (f) | by deleting item (36) of paragraph 1 and substituting the following item:| “(36) | 3,4,5-Trimethoxy-α-methylphenethylamine (also known as TMA)”; |
|
|
| (g) | by inserting, immediately after item (8AA) of paragraph 15, the following item:| “(8AAB) | 1-(4-Chlorophenyl)-2-(dimethylamino)propan-1-one (also known as 4-Chloro-N,N-dimethylcathinone)”; |
|
|
| (h) | by deleting item (13) of paragraph 15 and substituting the following item:| “(13) | 2-(Ethylamino)-1-phenylpentan-1-one (also known as α-Ethylaminopentiophenone or N-Ethylpentedrone)”; |
|
|
| (i) | by deleting items (1), (1AAA), (1AA) and (1A) of paragraph 17 and substituting the following items:| “(1) | 1-Acetyl-N,N-diethyllysergamide (also known as N‑Acetyl‑LSD or ALD-52) and its acyclic secondary and tertiary amide structural isomers | | (1A) | N-(1-Adamantyl)-5-bromopentyl-1H-indazole-3-carboxamide (also known as 5-Bromo-APINACA or 5‑Bromo-AKB48) and its bromo positional isomers in the pentyl group | | (1AA) | 5-{3-[(1-Adamantyl)carbamoyl]-1H-indazole-1-yl}pentanoic acid | | (1AB) | N-(1-Adamantyl)-5-chloropentyl-1H-indazole-3-carboxamide (also known as 5-Chloro-APINACA or 5‑Chloro-AKB48) and its chloro positional isomers in the pentyl group | | (1AC) | N‑(Adamant‑1‑yl)‑1‑(cyclohexylmethyl)‑1H-indazole-3-carboxamide (also known as Adamantyl CHMINACA or SGT-37) | | (1AD) | N-(1-Adamantyl)-5-hydroxypentyl-1H-indazole-3-carboxamide and its hydroxy positional isomers in the pentyl group | | (1AE) | N-(1-Adamantyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as FUB-APINACA or FUB‑AKB48) and its fluoro positional isomers in the phenyl ring | | (1AF) | N-(1-Adamantyl)-5-fluoropentyl-1H-indazole-3-carboxamide (also known as 5-Fluoro-APINACA or 5F‑AKB48) and its fluoro positional isomers in the pentyl group | | (1AG) | N-(1-Adamantyl)-5-fluoropentyl-1H-indole-3-carboxamide (also known as 5-Fluoro-APICA or STS-135) and its fluoro positional isomers in the pentyl group”; |
|
|
| (j) | by inserting, immediately after item (2A) of paragraph 17, the following items:| “(2AA) | 5-{3-[(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]-1H-indazole-1-yl}pentanoic acid and its N‑(1-amino-1-oxohexan-2-yl) isomers | | (2AB) | 5-{3-[(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]-1H-indole-1-yl}pentanoic acid and its N‑(1‑amino-1-oxohexan-2-yl) isomers”; |
|
|
| (k) | by inserting, immediately after item (2C) of paragraph 17, the following item: | “(2CA) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as 5-Fluoro-ADBICA) and its N-(1-amino-1-oxohexan-2-yl) isomers and their respective fluoro positional isomers in the pentyl group”; |
|
|
| (l) | by inserting, immediately after item (2DA) of paragraph 17, the following item:| “(2DB) | 5-{3-[(1-Amino-3-methyl-1-oxobutan‑2‑yl)carbamoyl]-1H-indazole-1‑yl}pentanoic acid and its N-(1-amino-1‑oxopentan-2-yl) isomers”; |
|
|
| (m) | by inserting, immediately after item (2G) of paragraph 17, the following item:| “(2GA) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide (also known as AB-FUBICA) and its N-(1-amino-1-oxopentan-2‑yl) isomers and their respective fluoro positional isomers in the phenyl ring”; |
|
|
| (n) | by inserting, immediately after item (6F) of paragraph 17, the following item:| “(6G) | [1-(5-Bromopent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as 5‑Bromo-UR-144) and its bromo positional isomers in the pentyl group”; |
|
|
| (o) | by inserting, immediately after item (8AC) of paragraph 17, the following item:| “(8AD) | [1-(5-Chloropent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as 5‑Chloro‑UR-144) and its chloro positional isomers in the pentyl group”; |
|
|
| (p) | by inserting, immediately after item (19AA) of paragraph 17, the following item:| “(19AAB) | Ethyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as 5‑Fluoro-AEB or 5‑Fluoro-EMB-PINACA) and its pentanoate isomers and their respective fluoro positional isomers in the pentyl group”; |
|
|
| (q) | by deleting items (19ABA) and (19ABB) of paragraph 17 and substituting the following items:| “(19ABA) | 2-[1-(4-Fluorobenzyl)-1H-indazole-3-carboxamido]-3,3‑dimethylbutanoic acid and its hexanoic acid isomers and their respective fluoro positional isomers in the phenyl ring | | (19ABB) | 2-[1-(4-Fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoic acid and its 1‑pentanoic acid and 2-methylbutanoic acid isomers and their respective fluoro positional isomers in the phenyl ring | | (19ABC) | 2-[1-(4-Fluorobenzyl)-1H-indole-3-carboxamido]-3-methylbutanoic acid and its 1-pentanoic acid and 2-methylbutanoic acid isomers and their respective fluoro positional isomers in the phenyl ring | | (19ABD) | [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as FUB‑144 or FUB-UR-144) and its fluoro positional isomers in the phenyl ring | | (19ABE) | 2-[1-(4-Fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid and its hexanoic acid isomers and their respective fluoro positional isomers in the butyl group”; |
|
|
| (r) | by inserting, immediately after item (20C) of paragraph 17, the following item:| “(20D) | 2-[1-(5-Fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoic acid and its 1-pentanoic acid and 2‑methylbutanoic acid isomers and their respective fluoro positional isomers in the pentyl group”; |
|
|
| (s) | by inserting, immediately after item (27AA) of paragraph 17, the following item:| “(27AB) | [1-(5-Hydroxypent-1-yl)-1H-indol-3-yl](2,2,3,3‑tetramethylcyclopropyl)methanone and its hydroxy positional isomers in the pentyl group”; |
|
|
| (t) | by inserting, immediately after item (27E) of paragraph 17, the following item:| “(27F) | N-[1-(3-Methoxyphenyl)cyclohexyl]-piperidine (also known as 3-Methoxyphencyclidine or 3‑Methoxy‑PCP or 3-MeO-PCP) and its methoxy positional isomers in the phenyl ring”; |
|
|
| (u) | by inserting, immediately after item (28C) of paragraph 17, the following item:| “(28CA) | Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (also known as MDMB-4en-PINACA or MDMB-PINACA N1‑pentyl-4-en isomer or MDMB(N)-022) and its hexanoate isomers and their respective pentenyl positional isomers in the pentyl group”; |
|
|
| (v) | by deleting item (28H) of paragraph 17 and substituting the following item:| “(28H) | Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3‑carboxamido]-3-methylbutanoate (also known as 5-Fluoro-AMB or 5-Fluoro-MMB-PINACA) and its pentanoate isomers and their respective fluoro positional isomers in the pentyl group”; |
|
|
| (w) | by inserting, immediately after item (28I) of paragraph 17, the following item:| “(28J) | Methyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3-phenylpropanoate (also known as 5-Fluoro-MPP-PICA or 5-Fluoro-MPhP-PICA or MPHP-2201) and its fluoro positional isomers in the pentyl group”; |
|
|
| (x) | by inserting, immediately after item (38) of paragraph 17, the following item:| “(38AA) | 4-{3-[(2-Phenylprop-2-yl)carbamoyl]-1H-indazole-1-yl}butanoic acid and its phenylpropyl isomers”; and |
|
|
| (y) | by inserting, immediately after item (39) of paragraph 17, the following item:| “(40) | 5-[3-(2,2,3,3-Tetramethylcyclopropanecarbonyl)-1H-indol-1-yl]pentanoic acid”. |
|
|
